Status:
UNKNOWN
Investigation of U1-A Uterine Anomalies Implantation Markers From the Lateral Walls of the Endometrium
Lead Sponsor:
Ufuk University
Conditions:
T-Shaped Uterus
Infertility, Female
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Various types and classes of uterine malformations have been identified and the ESHRE / ESGE classification system has recently been published on female genital system anomalies. Postoperative positiv...
Eligibility Criteria
Inclusion
- 18-45 age,
- Have no systemic disease,
- ESGE U1-A having uterine anomaly,
- Primary infertile, recurrent implantation loss, recurrent pregnancy loss history,
- Not having previous uterine surgery.
Exclusion
- Patients over the age of 45 under the age of 18,
- Those with systemic disease (Hypertension, Heart Disease, Asthma, Renal Disease, Liver Disease, Epilepsy),
- Having previous uterine surgery,
- Those who gave birth.
Key Trial Info
Start Date :
December 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04501003
Start Date
December 12 2019
End Date
May 1 2021
Last Update
November 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ufuk University
Ankara, Çankaya, Turkey (Türkiye), 06520